Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Ziding Feng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-3051-8882; OpenAlex author ID A5058030955; NIH RePORTER profile ID 2110020. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 1, last author 2)
Trials
1 (principal investigator on 1)
Grants
1
Labs led
2
Collaborators
78
Papers, trials and grants by year

2018: 5 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper, 1 trial · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 3 papers, 1 grant

Papers 13

  1. Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. Last author DOI 10.1053/j.gastro.2025.06.025↗
  2. Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. First author DOI 10.1093/jnci/djaf291↗
  3. Assessment of impending pancreatic cancer in a cohort of new onset diabetes on basis of biomarker trajectory Co-author DOI 10.64898/2026.08.06.26359908↗
  4. Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detectio… Last author DOI 10.1016/j.cct.2021.106659↗
  5. Potential Cost-Effectiveness of Risk-Based Pancreatic Cancer Screening in Patients With New-Onset Diabetes. Co-author DOI 10.6004/jnccn.2020.7798↗
  6. CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. Co-author DOI 10.1200/po.19.00330↗
  7. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Co-author DOI 10.1038/s41467-018-08109-6↗
  8. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy126↗
  9. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. Co-author DOI 10.1053/j.gastro.2018.05.023↗
  10. Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality. Co-author DOI 10.1097/mpa.0000000000001167↗
  11. A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001169↗
  12. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the … Co-author DOI 10.1097/mpa.0000000000001170↗
  13. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pan… Co-author DOI 10.1097/mpa.0000000000001171↗

Trials 1

  1. Early Detection Initiative for Pancreatic Cancer Principal investigator NCT04662879↗

Grants 1

  1. Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) U01DK108328↗

Closest collaborators

The 25 strongest of 78 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 8 shared papers, 1 shared trial, 1 shared grant, 2018–2026 · strength 2.19
  2. Suresh T. Chari · 8 shared papers, 1 shared trial, 2018–2026 · strength 1.51
  3. Bechien U. Wu · 4 shared papers, 2022–2026 · strength 0.89
  4. Lynn McCormick Matrisian · 4 shared papers, 2021–2026 · strength 0.82
  5. Suyu Liu · 1 shared grant, 2026 · strength 0.77
  6. Liang Li · 1 shared grant, 2026 · strength 0.77
  7. Ying Yuan · 1 shared grant, 2026 · strength 0.77
  8. William E Fisher · 2 shared papers, 1 shared trial, 2021–2026 · strength 0.76
  9. Barbara J. Kenner · 3 shared papers, 2022–2026 · strength 0.66
  10. Ying‐Qi Zhao · 3 shared papers, 2022–2026 · strength 0.66
  11. Jo Ann Rinaudo · 6 shared papers, 2018–2026 · strength 0.63
  12. Phil A. Hart · 5 shared papers, 2018–2026 · strength 0.63
  13. Jody V. Vykoukal · 4 shared papers, 2019–2026 · strength 0.45
  14. Samir Hanash · 4 shared papers, 2019–2026 · strength 0.45
  15. Avinash R. Kambadakone · 2 shared papers, 2022–2026 · strength 0.44
  16. Sudhir Srivastava · 5 shared papers, 2018–2022 · strength 0.42
  17. Johannes Francois Fahrmann · 3 shared papers, 2019–2026 · strength 0.38
  18. Ehsan Irajizad · 2 shared papers, 2020–2026 · strength 0.31
  19. José Serrano · 4 shared papers, 2018 · strength 0.28
  20. Stephen Jacob Pandol · 4 shared papers, 2018 · strength 0.28
  21. MD, FRCR Avinash Kambadakone-Ramesh · 1 shared trial, 2021 · strength 0.24
  22. Bechien Wu · 1 shared trial, 2021 · strength 0.24
  23. Matthew R. Young · 1 shared paper, 2026 · strength 0.23
  24. Eugene Jon Koay · 1 shared paper, 2026 · strength 0.23
  25. Florencia M. McAllister · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.